An LVO stroke is an ischemic stroke caused by a blood clot blocking one of the brain’s major arteries. “LVO” stands for large vessel occlusion, and these strokes are among the most dangerous. While they account for roughly 39% of all acute ischemic strokes, they’re responsible for over 60% of post-stroke disability and more than 95% of stroke-related deaths. The outsized impact comes down to anatomy: large arteries supply blood to vast regions of brain tissue, so a blockage in one can cause widespread damage within minutes.
Which Arteries Are Involved
The arteries most commonly affected are the internal carotid artery, the middle cerebral artery (particularly its first major branch, called the M1 segment), and the basilar artery at the back of the brain. These are the main highways of cerebral blood flow. When a clot lodges in one, it cuts off oxygen to a large territory of brain cells rather than a small, isolated patch. That’s the key distinction between an LVO stroke and a stroke caused by a blockage in a smaller, more peripheral vessel.
Most LVO strokes fall into the “anterior circulation” category, meaning they affect the front part of the brain supplied by the carotid and middle cerebral arteries. These regions control movement, speech, and sensation on one side of the body. Posterior circulation LVOs involving the basilar artery are less common but can affect consciousness, balance, and vital functions controlled by the brainstem.
Symptoms and Severity
LVO strokes typically produce sudden, severe neurological deficits. The classic signs include one-sided weakness or paralysis, difficulty speaking or understanding language, vision loss in one visual field, and facial drooping. Because so much brain tissue is at risk, symptoms tend to be more dramatic than those of smaller strokes.
Doctors use a scoring system called the NIHSS (National Institutes of Health Stroke Scale) to rate symptom severity on a scale from 0 to 42. Higher scores indicate worse deficits. Most LVO patients score well above 5, but here’s an important wrinkle: somewhere between 4% and 11% of patients with mild symptoms (scores of 5 or below) actually have a large vessel occlusion. A person might have only isolated speech difficulty or weakness in one hand, yet harbor a dangerous clot in a major artery. These “mild but disabling” presentations can be deceptive, which is why imaging is essential for diagnosis.
How an LVO Stroke Is Diagnosed
The gold standard for identifying an LVO is CT angiography (CTA), a rapid imaging scan that uses contrast dye to visualize the brain’s blood vessels in detail. Standard CT scans can show signs of stroke but often can’t pinpoint where a clot is sitting. CTA maps the arteries directly, revealing exactly which vessel is blocked and how much blood flow remains.
In some cases, doctors also use CT perfusion imaging, which measures blood flow through brain tissue in real time. This is especially valuable for patients who arrive later after symptom onset, because it can distinguish between brain tissue that has already died and tissue that is starved of blood but still salvageable. That distinction determines whether aggressive treatment is worthwhile.
Before patients ever reach the hospital, paramedics use quick screening tools to identify likely LVO cases in the field. One widely validated tool is the Los Angeles Motor Scale (LAMS), which tests arm and hand strength along with facial symmetry. When paramedics score a patient as likely having an LVO, they can bypass a smaller community hospital and route the patient directly to a comprehensive stroke center equipped for advanced treatment. This decision can save critical time.
Treatment: Clot-Busting Drugs and Thrombectomy
The first line of treatment is intravenous clot-dissolving medication, given as soon as possible after symptoms begin. A newer drug called tenecteplase has shown promising results compared to the older standard. In a trial published in the New England Journal of Medicine, 22% of LVO patients treated with tenecteplase had significant restoration of blood flow before any surgical procedure, compared to 10% of those given the older medication. That’s more than double the early recanalization rate.
However, clot-dissolving drugs alone often aren’t enough to reopen a large artery. The definitive treatment for LVO stroke is mechanical thrombectomy, a procedure in which a specially trained physician threads a thin catheter through an artery (usually starting at the groin) up to the brain and physically removes the clot. This procedure has transformed LVO stroke outcomes over the past decade.
Current European and American guidelines strongly recommend thrombectomy for patients who arrive within 6 hours of symptom onset. For patients arriving between 6 and 24 hours, thrombectomy is still recommended if brain imaging shows there is salvageable tissue remaining. This extended window was established by two landmark clinical trials. The DEFUSE-3 trial found that patients treated with thrombectomy 6 to 16 hours after symptom onset were far more likely to achieve functional independence at 90 days: 45% in the thrombectomy group versus 17% with medical treatment alone. Mortality at 90 days was also lower, at 14% compared to 26%.
The DAWN trial pushed the window even further, to 24 hours, for carefully selected patients whose imaging showed a small area of dead tissue relative to their clinical symptoms. Both trials focused on patients with clots in the middle cerebral artery or internal carotid artery.
Outcomes and Recovery
Outcomes after an LVO stroke depend heavily on how quickly blood flow is restored and how much brain tissue is saved. Functional independence at 90 days, defined as being able to carry out daily activities without significant help, is the benchmark doctors track.
The difference between receiving thrombectomy and not receiving it can be stark. Even in the most challenging patients, such as those over age 90, thrombectomy made a measurable difference in one study: 28.6% achieved a favorable outcome compared to just 6.9% of those managed with medication alone. Among those older patients, 20.4% in the thrombectomy group reached full functional independence versus only 1% in the medical management group.
Recovery timelines vary widely. Some patients regain significant function within weeks, while others face months of rehabilitation for speech, movement, or cognitive difficulties. The amount of brain tissue lost before blood flow is restored is the strongest predictor. This is why the phrase “time is brain” is central to stroke care: every minute of delayed treatment means more tissue lost and a harder path to recovery.
Why Speed Matters at Every Step
The entire system of LVO stroke care is built around compressing time. Paramedics screen in the field and route patients to the right hospital. Emergency departments have protocols to get CTA imaging done within minutes of arrival. Stroke teams are activated before the patient reaches the scanner. Each link in that chain exists because the data is unambiguous: faster treatment means better outcomes.
If you recognize sudden one-sided weakness, speech difficulty, facial drooping, or vision changes in someone, calling emergency services immediately is the single most important action. Driving to the hospital yourself risks arriving at a facility that lacks thrombectomy capability, costing time that the brain cannot afford to lose.